Thymosin Alpha-1 Calms Cytokine Storm in COVID-19 Blood Cells
Thymosin alpha-1 (Tα1) mitigated cytokine storm responses in blood cells from COVID-19 patients, reducing excessive inflammatory signaling that drives severe disease.
Quick Facts
What This Study Found
Thymosin alpha-1 mitigated cytokine storm in COVID-19 patient blood cells by reducing excessive inflammatory cytokine production without broad immunosuppression.
Key Numbers
Cytokine signaling genes upregulated in COVID-19; Tα1 mitigated cytokine expression; CD8+ T cell subset specifically inhibited
How They Did This
Ex vivo study. Blood cells from COVID-19 patients treated with Tα1. Cytokine production measured. Inflammatory response modulation assessed.
Why This Research Matters
COVID-19 deaths are largely caused by cytokine storm, not the virus itself. A peptide that calms this storm without suppressing anti-viral immunity could save lives in severe cases.
The Bigger Picture
Tα1 is used clinically in several countries for immune modulation. Its ability to calm cytokine storms without broad immunosuppression makes it relevant not just for COVID-19 but for any condition involving hyperinflammatory immune responses.
What This Study Doesn't Tell Us
Ex vivo study (blood cells in a dish, not whole patient). Small patient sample implied. Tα1 effects on intact immune system during active infection may differ. Clinical outcome data from Tα1 COVID treatment not provided.
Questions This Raises
- ?Would Tα1 improve clinical outcomes when given to severe COVID patients?
- ?How does Tα1 modulate inflammation without suppressing anti-viral immunity?
- ?Could Tα1 treat cytokine storms from other causes (sepsis, CAR-T therapy)?
Trust & Context
- Key Stat:
- Calms without suppressing Tα1 reduced the excessive inflammatory response driving severe COVID-19 while maintaining immune function — modulation rather than suppression
- Evidence Grade:
- Low evidence: ex vivo study on patient blood cells. Clinical efficacy not demonstrated.
- Study Age:
- Published 2021. Tα1 for COVID-19 has been studied in several clinical settings since.
- Original Title:
- Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.
- Published In:
- Open forum infectious diseases, 8(1), ofaa588 (2021)
- Authors:
- Matteucci, Claudia(5), Minutolo, Antonella(2), Balestrieri, Emanuela(2), Petrone, Vita, Fanelli, Marialaura, Malagnino, Vincenzo, Ianetta, Marco, Giovinazzo, Alessandro, Barreca, Filippo, Di Cesare, Silvia, De Marco, Patrizia, Miele, Martino Tony, Toschi, Nicola, Mastino, Antonio, Sinibaldi Vallebona, Paola, Bernardini, Sergio, Rogliani, Paola, Sarmati, Loredana, Andreoni, Massimo, Grelli, Sandro, Garaci, Enrico
- Database ID:
- RPEP-05589
Evidence Hierarchy
Frequently Asked Questions
What is thymosin alpha-1?
Tα1 is a naturally occurring peptide from the thymus gland that modulates immune responses. It's approved in some countries for hepatitis B/C and as an immune booster. It uniquely calms excessive inflammation while maintaining anti-pathogen immunity.
Can it help with COVID-19?
This lab study shows Tα1 reduces the cytokine storm driving severe COVID-19 in patient blood cells. Clinical studies are mixed but supportive. It's not a first-line COVID treatment but may help in severe cases with hyperinflammation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05589APA
Matteucci, Claudia; Minutolo, Antonella; Balestrieri, Emanuela; Petrone, Vita; Fanelli, Marialaura; Malagnino, Vincenzo; Ianetta, Marco; Giovinazzo, Alessandro; Barreca, Filippo; Di Cesare, Silvia; De Marco, Patrizia; Miele, Martino Tony; Toschi, Nicola; Mastino, Antonio; Sinibaldi Vallebona, Paola; Bernardini, Sergio; Rogliani, Paola; Sarmati, Loredana; Andreoni, Massimo; Grelli, Sandro; Garaci, Enrico. (2021). Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.. Open forum infectious diseases, 8(1), ofaa588. https://doi.org/10.1093/ofid/ofaa588
MLA
Matteucci, Claudia, et al. "Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.." Open forum infectious diseases, 2021. https://doi.org/10.1093/ofid/ofaa588
RethinkPeptides
RethinkPeptides Research Database. "Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells Fro..." RPEP-05589. Retrieved from https://rethinkpeptides.com/research/matteucci-2021-thymosin-alpha-1-mitigates
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.